Nutex Health (NASDAQ: NUTX) insider transactions
In the twelve months to 10 November 2026, executives and directors of Nutex Health reported 1 open-market sale of 203 shares ($43,493) and 5 open-market purchases of 1,241 shares ($148,237), by 6 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 18 September 2026 | Saunders Scott J | Director | Open-market sale | −203 | $214.25 | 400 | Form 4 |
| 31 July 2026 | Jaumot Frank E | Director | Option exercise | +603 | — | 753 | Form 4 |
| 31 July 2026 | Grenas Cheryl Yvonne | Director | Option exercise | +603 | — | 670 | Form 4 |
| 31 July 2026 | Reed Michael Lee | Director | Option exercise | +603 | — | 670 | Form 4 |
| 31 July 2026 | Saunders Scott J | Director | Option exercise | +603 | — | 603 | Form 4 |
| 4 June 2026 | Spears Kelvin | Director | Other | +2,519 | — | 34,656 | Form 4 |
| 28 May 2026 | Vo Thomas T. | Chief Executive Officer | Other | +75,747 | — | 2,103,014 | Form 4 |
| 9 April 2026 | Vo Thomas T. | Chief Executive Officer | Other | +184,071 | — | 2,027,267 | Form 4 |
| 20 March 2026 | Jaumot Frank E | Director | Open-market purchase | +150 | $93.56 | 150 | Form 4 |
| 19 March 2026 | Hosseinion Warren | President | Open-market purchase | +252 | $94.07 | 7,765 | Form 4 |
| 17 March 2026 | Spears Kelvin | Director | Open-market purchase | +10 | $94.46 | 32,137 | Form 4 |
| 13 March 2026 | Montgomery Pamela W. | Chief Legal Officer-Healthcare | Open-market purchase | +79 | $88.87 | 2,758 | Form 4 |
| 10 March 2026 | Hosseinion Warren | President | Option exercise | +6,293 | — | 10,787 | Form 4 |
| 10 March 2026 | Hosseinion Warren | President | Shares withheld for tax | −3,274 | $86.22 | 7,513 | Form 4 |
| 10 March 2026 | Luqman Elisa V | Chief Legal Officer - SEC | Option exercise | +2,084 | — | 3,154 | Form 4 |
| 10 March 2026 | Luqman Elisa V | Chief Legal Officer - SEC | Shares withheld for tax | −784 | $86.22 | 2,370 | Form 4 |
| 10 March 2026 | Montgomery Pamela W. | Chief Legal Officer-Healthcare | Option exercise | +2,084 | — | 3,455 | Form 4 |
| 10 March 2026 | Montgomery Pamela W. | Chief Legal Officer-Healthcare | Shares withheld for tax | −776 | $86.22 | 2,679 | Form 4 |
| 10 March 2026 | Chang Michael L. | Chief Medical Officer | Option exercise | +2,084 | — | 83,125 | Form 4 |
| 10 March 2026 | Chang Michael L. | Chief Medical Officer | Shares withheld for tax | −769 | $86.22 | 82,356 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Nutex Health page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.